- Home
- INBK vs ELTX Comparison
INBK vs ELTX Comparison
Compare INBK & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBK | ELTX |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | 355 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.3M | 209.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | INBK | ELTX |
|---|---|---|
| Price | $24.52 | $12.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.25 | $18.00 |
| AVG Volume (30 Days) | 49.4K | ★ 110.2K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | N/A | ★ 39.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,301,000.00 |
| Revenue This Year | $279.34 | N/A |
| Revenue Next Year | $12.97 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.05 | $4.70 |
| 52 Week High | $28.51 | $14.93 |
Technical Indicators
Market Signals| Indicator | INBK | ELTX |
|---|---|---|
| Relative Strength Index (RSI) | 73.84 | 59.69 |
| Support Level | $23.25 | $9.85 |
| Resistance Level | $24.91 | $12.52 |
| Average True Range (ATR) | 0.94 | 0.95 |
| MACD | 0.25 | 0.26 |
| Stochastic Oscillator | 92.79 | 64.98 |
Price Performance
Historical ComparisonAbout INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.